RVMD · Categories · Upgrades
RVMD - Analyst upgrades
Revolution Medicines Inc. (RVMD) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for RVMD
- Revolution Medicines upgraded by Raymond James with a new price targetRaymond James upgraded Revolution Medicines from Outperform to Strong Buy and set a new price target of $48.00 from $36.00 previously
- Revolution Medicines upgraded by BofA Securities with a new price targetBofA Securities upgraded Revolution Medicines from Neutral to Buy and set a new price target of $34.00 from $31.00 previously
- Revolution Medicines upgraded by JP Morgan with a new price targetJP Morgan upgraded Revolution Medicines from Neutral to Overweight and set a new price target of $38.00 from $32.00 previously
- Revolution Medicines upgraded by Stifel with a new price targetStifel upgraded Revolution Medicines from Hold to Buy and set a new price target of $26.00 from $36.00 previously